Literature DB >> 25765295

Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.

Kui Young Park1, Moo Yeol Hyun, Se Yeong Jeong, Beom Joon Kim, Myeung Nam Kim, Chang Kwun Hong.   

Abstract

BACKGROUND: Persistent erythema and severe rosacea flushing can cause significant physical discomfort and emotional stress to patients. Currently, no satisfactory treatments are available.
METHODS: We report two cases of refractory flushing and erythema of rosacea that were successfully treated with intradermal botulinum toxin injections.
RESULTS: Good cosmetic results were achieved for both patients. The side effects during and after treatment were mild pain and localized bruising; these symptoms resolved within several days without further treatment.
CONCLUSION: Intradermal botulinum toxin injection may be an effective treatment for refractory erythema and rosacea flushing that deserves further study in a larger patient population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25765295     DOI: 10.1159/000368773

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  16 in total

Review 1.  Botulinum Toxin Off-Label Use in Dermatology: A Review.

Authors:  Anna Campanati; Emanuela Martina; Katia Giuliodori; Veronica Consales; Ivan Bobyr; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2017-02-01

Review 2.  Rosacea Management.

Authors:  Manal Abokwidir; Steven R Feldman
Journal:  Skin Appendage Disord       Date:  2016-05-18

3.  Botulinum toxin blocks mast cells and prevents rosacea like inflammation.

Authors:  Jae Eun Choi; Tyler Werbel; Zhenping Wang; Chia Chi Wu; Tony L Yaksh; Anna Di Nardo
Journal:  J Dermatol Sci       Date:  2018-12-28       Impact factor: 4.563

4.  Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.

Authors:  Andres Luque; Aida Paola Rojas; Andrea Ortiz-Florez; Juliana Perez-Bernal
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

Review 5.  Skin neurogenic inflammation.

Authors:  Jae Eun Choi; Anna Di Nardo
Journal:  Semin Immunopathol       Date:  2018-04-30       Impact factor: 9.623

6.  A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.

Authors:  Kui Young Park; Hyun Jung Kwon; Jae Min Kim; Guk Jin Jeong; Beom Joon Kim; Seong Jun Seo; Myeong Nam Kim
Journal:  Ann Dermatol       Date:  2018-10-26       Impact factor: 1.444

Review 7.  New Uses of AbobotulinumtoxinA in Aesthetics.

Authors:  Joel Schlessinger; Erin Gilbert; Joel L Cohen; Joely Kaufman
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

Review 8.  Psychosocial aspects of rosacea with a focus on anxiety and depression.

Authors:  Monika Heisig; Adam Reich
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-03-06

9.  The Efficacy and Safety of Fractional CO₂ Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study.

Authors:  Jie Zhu; Xi Ji; Min Li; Xiao-e Chen; Juan Liu; Jia-an Zhang; Dan Luo; Bing-rong Zhou
Journal:  Biomed Res Int       Date:  2016-02-22       Impact factor: 3.411

10.  Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT).

Authors:  Lili Bai; Xiaobo Peng; Yanqing Liu; Yawei Sun; Xin Wang; Xingwang Wang; Guodong Lin; Peng Zhang; Kun Wan; Zewu Qiu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.